๋ฉํธ๋ ๋ธ๋ฃจ
๋ฉํธ๋ ๋ธ๋ฃจ๋ **ํฐ์์ง ์ผ๋ฃ**๋ก, ์ฃผ๋ก ๋ฐ์ถ๋๋ฌผ์์ ์ง์ฐ์ผ์ด๋ ์ผ์์ฐ์ผ๊ณผ ๊ฐ์ ์ฐํ์ ์ ์ํด ์ ๋ฐ๋ **๋ฉํธํค๋ชจ๊ธ๋ก๋นํ์ฆ**์ ์น๋ฃํ๋ **ํด๋ ์ **๋ก ์ฌ์ฉ๋ฉ๋๋ค. ๋ํ ์์ํ๋ฌผ ์ค๋ ์ ๋ณด์กฐ ๋๋ ๋์ฒด ์๋ฒ์ผ๋ก๋ ๊ฐํน ์ฌ์ฉ๋ฉ๋๋ค. ์๋๋ฌผ ์ํ์์๋ ๊ฐ ์ท์ฅ์ **์ท๋์ธํฌ์ข (์ธ์๋ฆฐ์ข )**์ ์ฐ์ ์ ์ผ๋ก ์ผ์ํ๊ธฐ ์ํ ์์ ์ค ์ ๋งฅ ๋ด ์ผ์์ ๋ก ๋ ํนํ๊ฒ ์ฌ์ฉ๋์ด ์ธ๊ณผ์ ์ ์ ๋ฅผ ๋์ต๋๋ค. **์์ ์์ :** * ๋ฉํธ๋ ๋ธ๋ฃจ๋ ์ญ์ค์ ์ธ ์ฉ๋ ์์กด์ ํจ๊ณผ๋ฅผ ๊ฐ์ง๋๋ค. ์ ์ฉ๋์์๋ ๋ฉํธํค๋ชจ๊ธ๋ก๋นํ์ฆ์ ์น๋ฃํ๋ ํ์์ ๋ก ์์ฉํ์ง๋ง, ๊ณ ์ฉ๋์์๋ ์ฐํ์ ๋ก ์์ฉํ์ฌ ์คํ๋ ค ๋ฉํธํค๋ชจ๊ธ๋ก๋นํ์ฆ์ *์ ๋ฐ*ํ ์ ์์ต๋๋ค. * ๊ณ ์์ด๋ ์ด ์ฝ๋ฌผ๋ก ์ธํ ์ฐํ์ ์์์ ๋งค์ฐ ๋ฏผ๊ฐํ๋ฏ๋ก, ๊ณ ์์ด ํ์์์์ ์ฌ์ฉ์ ๋ ผ๋์ ์ฌ์ง๊ฐ ๋ง์ผ๋ฉฐ ์ผ๋ฐ์ ์ผ๋ก ๊ธ๊ธฐ๋ก ๊ฐ์ฃผ๋ฉ๋๋ค.
์์ฉ ๊ธฐ์ : Methylene blue acts as an artificial electron acceptor and donor in red blood cells. * **Reduction Pathway:** In the tissues, methylene blue interacts with the enzyme **NADPH-methemoglobin reductase**. It is rapidly reduced to **leucomethylene blue**. * **Hemoglobin Conversion:** Leucomethylene blue serves as a reducing agent (electron donor) โ converts **methemoglobin (Fe3+)** back to functional oxygen-carrying **hemoglobin (Fe2+)**. * **Oxidation Pathway (High Doses):** Methylene blue is inherently an oxidizing agent. If administered at high doses (species dependent), it overwhelms the reduction pathway and directly oxidizes hemoglobin โ **causes methemoglobinemia**.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- For methemoglobin-producing toxins (nitrites, nitrates, chlorates) ยท 4-15 mg/kg (Using a 1% solution) ยท IV ยท q6h ยท As needed
- For cyanide toxicity ยท 4-6 grams per 454 kg (1000 lb.) of body weight ยท IV ยท Once ยท Once
- For methemoglobin-producing toxins (nitrites, nitrates, chlorates) ยท 4-15 mg/kg (Using a 1% solution) ยท IV ยท q6h ยท As needed
- For cyanide toxicity ยท 4-6 grams per 454 kg (1000 lb.) of body weight ยท IV ยท Once ยท Once
- Methemoglobinemia secondary to phenol exposure ยท 1.5 mg/kg ยท IV ยท Single, slow infusion ยท Once ยท May use with 20 mg/kg ascorbic acid PO.
- Methemoglobinemia ยท 1-1.5 mg/kg ยท IV ยท one time only ยท Once
- Severe methemoglobinemia ยท 1 mg/kg as a 1% solution ยท IV ยท given slowly over several minutes ยท May be repeated if necessary ยท Use cautiously (can cause Heinz body anemia). Measure hematocrit for 3 days.
- For methemoglobin-producing toxins (nitrites, nitrates, chlorates) ยท 4-15 mg/kg (Using a 1% solution) ยท IV ยท q6h ยท As needed
- For nitrate poisoning ยท 5-15 mg/kg as a 1% solution in physiologic saline ยท IV ยท Once ยท Repeat treatment at a lower dose may be required in severe cases ยท In animals that do not succumb, recovery occurs by 24 hours.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Cats (considered contraindicated by most clinicians due to severe sensitivity)
- Renal insufficiency
- Hypersensitivity to methylene blue
- Intraspinal (intrathecal) injection
- Lactating dairy animals
- Severe renal impairment
- Patients with G6PD deficiency (can cause severe hemolysis)
- Use with extreme caution in cats due to high susceptibility to Heinz body formation
์ด์๋ฐ์
- Heinz body anemia
- Red cell morphological changes
- Methemoglobinemia (at high doses)
- Decreased red blood cell life span
- Necrotic abscesses (if injected SC or extravasated IV)
- Green-blue discoloration of urine
- Heinz body anemia (especially in cats)
- Paradoxical methemoglobinemia (at high doses)
- Tissue necrosis (if extravasated)
- Blue/green discoloration of urine, feces, and mucous membranes
- Nausea and vomiting
์ฝ๋ฌผ ์ํธ์์ฉ
- SSRIs (e.g., Fluoxetine) ยท Methylene blue is a potent reversible monoamine oxidase inhibitor (MAOI); concurrent use can precipitate fatal serotonin syndrome. ยท major
- Tricyclic Antidepressants (TCAs) ยท Increased risk of serotonin toxicity. ยท major
๋ชจ๋ํฐ๋ง
- Methemoglobinemia levels
- Red cell morphology
- Red cell indices
- Hematocrit
- Hemoglobin
- Methemoglobin levels
- Complete Blood Count (CBC) for Heinz bodies and hemolysis
- Arterial blood gas (ABG)
- Renal function
- Signs of serotonin syndrome if on concurrent serotonergic drugs
๊ณผ์ฉ๋
The LD50 for IV administered 3% methylene blue is approximately 43 mg/kg in sheep. High doses can paradoxically cause methemoglobinemia due to the drug's inherent oxidizing properties.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.